Last reviewed · How we verify
Intra-vitreal Anti-VEGF Drug
Intra-vitreal Anti-VEGF Drug is a Small molecule drug developed by Retina Vitreous Associates of Florida. It is currently in Phase 1 development. Also known as: Lucentis, Avastin, Eylea.
At a glance
| Generic name | Intra-vitreal Anti-VEGF Drug |
|---|---|
| Also known as | Lucentis, Avastin, Eylea |
| Sponsor | Retina Vitreous Associates of Florida |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab (PHASE2)
- Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival (NA)
- Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intra-vitreal Anti-VEGF Drug CI brief — competitive landscape report
- Intra-vitreal Anti-VEGF Drug updates RSS · CI watch RSS
- Retina Vitreous Associates of Florida portfolio CI
Frequently asked questions about Intra-vitreal Anti-VEGF Drug
What is Intra-vitreal Anti-VEGF Drug?
Intra-vitreal Anti-VEGF Drug is a Small molecule drug developed by Retina Vitreous Associates of Florida.
Who makes Intra-vitreal Anti-VEGF Drug?
Intra-vitreal Anti-VEGF Drug is developed by Retina Vitreous Associates of Florida (see full Retina Vitreous Associates of Florida pipeline at /company/retina-vitreous-associates-of-florida).
Is Intra-vitreal Anti-VEGF Drug also known as anything else?
Intra-vitreal Anti-VEGF Drug is also known as Lucentis, Avastin, Eylea.
What development phase is Intra-vitreal Anti-VEGF Drug in?
Intra-vitreal Anti-VEGF Drug is in Phase 1.
Related
- Manufacturer: Retina Vitreous Associates of Florida — full pipeline
- Also known as: Lucentis, Avastin, Eylea
- Compare: Intra-vitreal Anti-VEGF Drug vs similar drugs
- Pricing: Intra-vitreal Anti-VEGF Drug cost, discount & access